Meghan Markle, Duchess of Sussex, continues to expand her impact beyond royal circles. On April 11, 2025, she stepped into the world of healthcare investing by backing Midi Health, a telehealth startup that focuses on providing care for women navigating menopause. This move not only signals her growing interest in supporting women-centric ventures but also brings much-needed attention to a health segment long neglected by mainstream medical innovation.
Let’s take a deep dive into this headline-making investment, what Midi Health stands for, and why Markle’s involvement could change the future of women’s healthcare.
A Closer Look at Midi Health
Founded in 2021, Midi Health aims to bridge the healthcare gap for women over 35, especially those going through perimenopause, menopause, and other midlife hormonal changes. The startup offers virtual consultations, personalized care plans, and access to licensed providers who specialize in hormonal health.
Midi Health positions itself as a long-term care provider. Instead of offering one-off consultations, it creates a comprehensive care journey, adjusting hormone therapy, supplements, lifestyle changes, and other treatments based on each patient’s evolving needs. The service supports women across all 50 U.S. states and accepts insurance, making it more accessible than many boutique hormone clinics.
The company focuses on evidence-based medicine. It combines hormone therapy with nutritional and behavioral support, tracking patient progress through a personalized dashboard. Unlike most telehealth startups that often target younger, urban audiences, Midi focuses on the neglected demographic of women in their late 30s to 60s—those too often left out of tech-enabled healthcare solutions.
Markle’s Involvement and Investment
Meghan Markle joins a group of high-profile investors in Midi Health’s $63 million Series B funding round. While the exact value of her investment remains undisclosed, reports estimate it could be as high as $500,000. She joins other notable female investors such as actress Gwyneth Paltrow and tennis legend Serena Williams, both of whom have also backed health and wellness-focused companies in recent years.
Markle didn’t just contribute financially. She actively supports the startup’s mission and plans to use her platform to advocate for open dialogue around women’s health and financial independence. In an interview following the investment announcement, Markle said:
“Women deserve access to healthcare that recognizes their unique journeys. We need to remove the shame around menopause and midlife transitions and replace it with support and knowledge.”
Her involvement carries more than financial weight. It injects cultural relevance and star power into a healthcare issue many still consider taboo. By investing in Midi Health, she sends a strong message: women’s health matters, and society needs to prioritize it now.
Why This Matters
1. Menopause Care Remains Severely Underfunded
Most healthcare innovations focus on fertility, pregnancy, or sexual wellness. Midlife hormonal health remains a massively underfunded and misunderstood segment. According to Rock Health, less than 5% of digital health funding goes toward menopause and related issues. Startups like Midi Health operate in a space where demand outpaces supply, and education often lags behind symptoms.
Meghan Markle’s endorsement shines a much-needed spotlight on this gap. With millions of women entering menopause every year, the market has enormous potential, not just financially but socially. Proper care can improve quality of life, reduce workplace absenteeism, and prevent long-term health risks like osteoporosis and heart disease.
2. The Power of Celebrity Advocacy
Meghan Markle’s influence extends far beyond tabloid headlines. When she talks, people listen. Her past involvement in mental health campaigns, gender equity initiatives, and racial justice discussions have sparked global conversations. Now, she brings that same attention to menopause—a subject often cloaked in silence and misinformation.
By putting her name behind Midi Health, Markle makes menopause mainstream. She humanizes the topic, reminding the public that every woman goes through this stage and deserves dignity, clarity, and care while doing so.
3. Changing the Investment Narrative
Historically, venture capitalists—mostly male—have overlooked femtech. But women like Meghan Markle are changing the narrative. Her investment aligns with a broader shift: more female investors now target impact-driven ventures that support women’s lives.
This change affects how entrepreneurs frame their pitches. Startups in femtech, menopause care, fertility, and maternal health now have examples like Midi Health to cite when speaking with investors. Meghan Markle’s involvement validates this growing segment and paves the way for more funding, innovation, and visibility.
What Sets Midi Health Apart
Midi Health stands out because it delivers whole-person care, not just prescriptions. Their practitioners follow a collaborative model, working with each patient over months or years. They personalize hormone therapy, monitor effects, adjust doses, and support patients emotionally as they move through various life phases.
Additionally, Midi accepts health insurance—a rare move in a sector where many menopause clinics operate on direct-pay or concierge models. This insurance-first approach democratizes care and allows women from all income groups to access expert help.
They’ve also partnered with large employers to offer menopausal care as a workplace benefit. Companies such as Salesforce and Microsoft have started integrating such services into their employee health plans, signaling that even corporate America recognizes the need for better midlife care.
Meghan Markle’s Larger Strategy
This investment also reflects Markle’s broader business evolution. Through her and Prince Harry’s Archewell Foundation and Archewell Productions, she has consistently pushed for social progress, media transparency, and wellness.
Now, she’s venturing into angel investing, and if Midi Health is any indication, her focus lies on ventures that align with her core values: equity, access, and empowerment.
Rather than backing generic tech or retail startups, Markle chooses companies that fill real social gaps. This strategy suggests that she’s not looking for quick exits but for long-term influence, both financially and culturally.
The Road Ahead for Midi Health
With the new funding, Midi plans to:
- Expand its clinical team to over 150 providers nationwide
- Enhance its technology platform for personalized tracking
- Introduce AI-powered care plans to optimize treatments
- Partner with more employers to reach women in the workforce
CEO Joanna Strober stated that Markle’s involvement adds not just capital but also cultural firepower. She hopes that more women will seek care without shame and start viewing menopause as a manageable, not mysterious, life stage.
Conclusion
Meghan Markle’s investment in Midi Health does more than back a promising startup. It reframes menopause as a public health priority, encourages dialogue around women’s hormonal health, and opens the door for more innovation in femtech.
Her involvement signals to the world that wellness isn’t just about skincare and supplements—it includes the full spectrum of women’s experiences, especially the ones society still hesitates to discuss. By choosing to invest in Midi Health, Markle makes a powerful statement: women deserve support at every stage, not just when they’re young, fertile, or marketable.
And with this bold move, she just may help rewrite the rules of venture capital, healthcare access, and public awareness—one investment at a time.